Nike's Restructuring Confirms Turnaround Delays as Sales Slide and Costs Rise

What happened

The Motley Fool article confirms Nike's business restructuring amid declining sales and rising costs, which aligns with the Q1 FY27 results already detailed in the latest filings. Management's Pace program targets $2.5 billion in cumulative savings by FY31 but requires $1 billion in pre-tax charges, with $0.3 billion expected in FY27. Gross margin improved 60 basis points to 42.8%, but the gain came from lower logistics costs and FX, not pricing power, as higher discounts and channel mix reduced average selling prices. The report already highlighted extended turnaround timelines in Greater China, Sportswear, and Jordan, and this article adds no new specifics but reinforces the ongoing operational strain. Overall, the news does not alter the underlying thesis but corroborates the need for cost restructuring while top-line recovery remains elusive.

Implication

Investors should interpret the restructuring as a clear sign that revenue repair is lagging, prompting management to prioritize cost cuts over near-term growth. The stock already reflects much of this negativity, but with FY27 guidance for a high-single-digit revenue decline, downside risk persists if Greater China fails to improve. The attractive entry remains near $30, where the balance sheet strength provides a margin of safety. An upgrade would require evidence of wholesale turning positive, Direct declines narrowing, and average selling prices stabilizing. Until then, capital preservation is prudent, with close monitoring of Investor Day milestones, China trends, and ASP commentary.

Thesis delta

The restructuring article adds no new information beyond confirming the cost and sales pressures already reflected in our thesis. The core view remains unchanged: the turnaround is extended, and current valuation lacks sufficient upside. We maintain our WAIT rating and $30 attractive entry.